Investing

Opening Bell Analysts Research Calls for Tuesday, January 3

This report was sent to Briefing.com subscribers earlier today. 

Research calls posted earlier this morning are available here

Upgrades:

> ACADIA Pharmaceuticals (ACAD) upgraded to Buy from Neutral at Guggenheim; tgt $22

> Allegion (ALLE) upgraded to Buy from Hold at Vertical Research; tgt $128

> Becton Dickinson (BDX) upgraded to Buy from Neutral at BofA Securities; tgt raised to $290

> Block (SQ) upgraded to Outperform from Neutral at Robert W. Baird; tgt raised to $78

> Blueprint Medicines (BPMC) upgraded to Equal Weight from Underweight at Wells Fargo; tgt $41

> CACI Intl (CACI) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $355

> Coty (COTY) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $10

> Credicorp LTD (BAP) upgraded to Outperform from Market Perform at Itau BBA; tgt $156

> CRH Plc. (CRH) upgraded to Buy from Neutral at Redburn

> Healthpeak (PEAK) upgraded to Buy from Hold at Jefferies; tgt raised to $29

> Immunovant Sciences (IMVT) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $27

> Intevac (IVAC) upgraded to Buy from Hold at The Benchmark Company; tgt $9

> KeyCorp (KEY) upgraded to Equal Weight from Underweight at Barclays; tgt raised to $24

> M&T Bank (MTB) upgraded to Outperform from Neutral at Wedbush; tgt $170

> Monte Rosa Therapeutics (GLUE) upgraded to Overweight from Equal Weight at Wells Fargo; tgt $18

> National Retail Properties (NNN) upgraded to Buy from Hold at Jefferies; tgt raised to $52

> PayPal (PYPL) upgraded to Buy from Hold at Truist; tgt $95

> Twist Bioscience (TWST) upgraded to Outperform from In-line at Evercore ISI; tgt raised to $36

> U.S. Bancorp (USB) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $68

> Universal Health (UHS) upgraded to Equal Weight from Underweight at Wells Fargo; tgt raised to $154

> Wynn Resorts (WYNN) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $101

Downgrades:

> Apellis Pharmaceuticals (APLS) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $58

> Apollo Global Management (APO) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt $77

> Arvinas (ARVN) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $49

> Baxter (BAX) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $55

> Blue Owl Capital (OWL) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt $13

> Carlyle Group (CG) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt $36

> Cigna (CI) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $355

> Citizens Financial Group (CFG) downgraded to Neutral from Outperform at Wedbush; tgt $45

> CVS Health (CVS) downgraded to In-line from Outperform at Evercore ISI; tgt lowered to $100

> Douglas Emmett (DEI) downgraded to Underperform from Hold at Jefferies; tgt lowered to $13

> Fox Corporation (FOXA) downgraded to Underperform from Peer Perform at Wolfe Research; tgt $28

> Futu Holdings (FUTU) downgraded to Reduce from Buy at CLSA; tgt $43

> Gilead Sciences (GILD) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt $87

> GlaxoSmithKline (GSK) downgraded to Underweight from Neutral at JP Morgan

> Health Catalyst (HCAT) downgraded to In-line from Outperform at Evercore ISI; tgt raised to $11

> Illinois Tool (ITW) downgraded to Hold from Buy at Vertical Research; tgt lowered to $220

> Independence Realty Trust (IRT) downgraded to Hold from Buy at Jefferies; tgt lowered to $17

> Informatica (INFA) downgraded to Neutral from Buy at UBS; tgt lowered to $18

> Invitation Homes (INVH) downgraded to Hold from Buy at Jefferies; tgt lowered to $31

> Kilroy Realty (KRC) downgraded to Hold from Buy at Jefferies; tgt lowered to $39

> Life Storage (LSI) downgraded to Hold from Buy at Jefferies; tgt lowered to $97

> Lions Gate Entertainment (LGF.A) downgraded to Underperform from Peer Perform at Wolfe Research; tgt $5

> M&T Bank (MTB) downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $194

> Molson Coors Brewing (TAP) downgraded to Underweight from Equal Weight at Wells Fargo; tgt lowered to $45

> Mondelez Int’l (MDLZ) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt $69

> Parsons (PSN) downgraded to Underweight from Equal-Weight at Morgan Stanley; tgt $40

> PG&E (PCG) downgraded to Neutral from Buy at UBS; tgt $17

> Pulmonx (LUNG) downgraded to Underperform from Neutral at BofA Securities; tgt $8

> Reynolds Consumer Products (REYN) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt $30

> SAGE Therapeutics (SAGE) downgraded to Neutral from Buy at Guggenheim

> Science Applications (SAIC) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt raised to $114

> Shaw Comms (SJR) downgraded to Sector Perform from Outperform at RBC Capital Mkts

> T-Mobile US (TMUS) downgraded to Peer Perform from Outperform at Wolfe Research

> Zimmer Biomet (ZBH) downgraded to In-line from Outperform at Evercore ISI; tgt $130

> Zions Bancorp (ZION) downgraded to Underweight from Equal Weight at Barclays; tgt lowered to $59

Others:

> Kraft Heinz (KHC) initiated with an Equal Weight at Wells Fargo; tgt $43

> Mondelez Int’l (MDLZ) initiated with an Overweight at Wells Fargo; tgt $75

> OraSure (OSUR) resumed with an In-line at Evercore ISI; tgt $5

> Selina Hospitality PLC (SLNA) initiated with a Buy at EF Hutton; tgt $6.50

> Supernus Pharma (SUPN) assumed with a Buy at Jefferies; tgt raised to $45

> Syndax Pharmaceuticals (SNDX) initiated with an Overweight at JP Morgan; tgt $41

Sponsored: Tips for Investing

A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.

Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.